Dimi Comfu

Biomarker discovery in cancer is challenging due to data complexity, inherent tumor heterogeneity, and technological limitations. Spatial biology offers a transformative solution by allowing researchers to study cancer biology in situ, identify biomarkers, and evaluate treatment responses with greater precision. This article will review various spatial biology approaches that are advancing the discovery of biomarkers predicting responses to cancer immunotherapy.

Product Name: Human TNF alpha uncoated ELISA Info: We tested this kit in exosomes, both in total exosomes and immunopurified (according to neuronal source). The kit performed well, and the standards were clear/easily read. The samples, however, weren't detected using 1:1 dilution, so an optimization is required for this type of sample to fix this issue. Even some pure plasma samples were not detected, which reinforces the idea that dilution is not required for this type of application/sample.

Product Name: beta Tubulin Loading Control Monoclonal Antibody (BT7R) Catalog Number: MA5-16308 As a researcher, I find Western blotting to be a powerful technique for investigating protein stability, interactions, and expression levels. To ensure the accuracy of my results, incorporating a loading control is a critical step in my experimental workflow. For this purpose, I consistently rely on the beta-tubulin antibody due to its stability and widespread presence in eukaryotic cells.